Carbaglu (Orphan Europe, SARL)


Welcome to the PulseAid listing for the Carbaglu drug offered from Orphan Europe, SARL. This Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Orphan Europe, SARL
NON-PROPRIETARY NAME: Carglumic Acid
SUBSTANCE NAME: CARGLUMIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Carbamoyl Phosphate Synthetase 1 Activator [EPC],Carbamoyl Phosphate Synthetase 1 Activators [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2010-03-18
END MARKETING DATE: 0000-00-00


Carbaglu HUMAN PRESCRIPTION DRUG Details:

Item DescriptionCarbaglu from Orphan Europe, SARL
LABELER NAME: Orphan Europe, SARL
DEA SCHEDULE:
ACTIVE STRENGTH: 200(mg/1)
START MARKETING DATE: 2010-03-18
END MARKETING DATE: 0000-00-00
PRODUCT ID: 52276-312_9e3720cb-15e2-ac00-e3de-3c4c82870d33
PRODUCT NDC: 52276-312
APPLICATION NUMBER: NDA022562

Other CARGLUMIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Orphan Europe, SARLCarbaglu